The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
The High Court has directed Yaw Odame-Darkwa, a former board member of the Ghana Infrastructure Investment Fund (GIIF) and key prosecution witness, to retrieve, verify, and submit 16 specific emails ...
Objective To compare the short-term, mid-term and long-term effects between three interventions (education only, education and strengthening exercises, education and motor control exercises) for ...
Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback